Jin Sun

65PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)NanomaterialsGlycoconjugatesPredictive and prognostic markersMicro- and nanosystems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|May 01, 2026
Non-Engineered Physiologically Modulated Nanovesicles Augment Antitumor Immune Responses via Dual-Pathway T Cell Activation.

|Apr 22, 2026
Modification-Response Integrated Modules Driven Cyclization-Dependent Prodrug Self-Assembly for Reshaping Pro-Apoptotic Tumor Redox Homeostasis.

|Feb 18, 2026
Reprogramming the In Vivo Fate of Nanoassemblies: Morphology Regulation to Rod-Like Nanostructures to Enhance Antitumor Efficacy.

Jingyi Zhang, Tian Liu, Yaqiao Li

|Jan 07, 2026
In Situ Sustained Delivery of Tumor Cell-Derived Extracellular Nanovesicles With Oncolytic Adenoviruses for Potentiating Cancer Immunotherapy.

Tianye Wang, Sheng Zhao, Zao Ji

|Jan 03, 2026
Hydrophobic/Amphiphilic Prodrug Coassembly Strategy: Exploring the Effect of Oligoethylene Glycol Chains on the Antitumor Efficacy of Nanoassemblies.

Jun Yuan, Shuo Wang, Wenjing Wang

|Dec 20, 2025
Correction: Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs.

Jian Zhao, Hao Ye, Qi Lu

Pageof 11

Frequent Collaborators

31 joint publications

Zhonggui He

11 joint publications

Bingjun Sun

9 joint publications

Kaiyuan Wang

3 joint publications

Xiaoyuan Chen